Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorGonzález-Martínez, Silvia
dc.contributor.authorPérez-Mies, Belén
dc.contributor.authorPizarro, David
dc.contributor.authorCaniego-Casas, Tamara
dc.contributor.authorCortés Castan, Javier
dc.contributor.authorPalacios, José
dc.date.accessioned2022-01-31T11:03:01Z
dc.date.available2022-01-31T11:03:01Z
dc.date.issued2021-07
dc.identifier.citationGonzález-Martínez S, Pérez-Mies B, Pizarro D, Caniego-Casas T, Cortés J, Palacios J. Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma. Int J Mol Sci. 2021 Jul;22(14):7398.
dc.identifier.issn1422-0067
dc.identifier.urihttps://hdl.handle.net/11351/6937
dc.descriptionTransició epitelial-mesenquimal; Carcinoma de mama metaplàstic
dc.description.sponsorshipThis review was funded by grants from the Instituto de Salud Carlos III (ISCIII) (PI19/01331) and CIBERONC (CB16/12/00316 and CB16/12/00449), co-financed by the European Development Regional Fund. ‘A way to achieve Europe’ (FEDER), and by the Spanish Association Against Cancer Scientific Foundation (Grupos Coordinados Traslacionales aecc 2018).
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesInternational Journal of Molecular Sciences;22(14)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectMama - Càncer - Tractament
dc.subjectCèl·lules - Transformació
dc.subjectFisiologia cel·lular
dc.subject.meshEpithelial-Mesenchymal Transition
dc.subject.mesh/drug effects
dc.subject.meshBreast Neoplasms
dc.subject.mesh/immunology
dc.titleEpithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/ijms22147398
dc.subject.decstransición epiteliomesenquimatosa
dc.subject.decs/efectos de los fármacos
dc.subject.decsneoplasias de la mama
dc.subject.decs/inmunología
dc.relation.publishversionhttps://doi.org/10.3390/ijms22147398
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[González-Martínez S] Clinical Researcher, Hospital Ramón y Cajal, 28034 Madrid, Spain. [Pérez-Mies B, Palacios J] Department of Pathology, Hospital Ramón y Cajal, 28034 Madrid, Spain. Institute Ramón y Cajal for Health Research (IRYCIS), 28034 Madrid, Spain. CIBER-ONC, Instituto de Salud Carlos III, 28029 Madrid, Spain. Faculty of Medicine, University of Alcalá de Henares, Alcalá de Henares, 28801 Madrid, Spain. [Pizarro D, Caniego-Casas T] Institute Ramón y Cajal for Health Research (IRYCIS), 28034 Madrid, Spain. [Cortés J] CIBER-ONC, Instituto de Salud Carlos III, 28029 Madrid, Spain. Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, 28670 Madrid, Spain. International Breast Cancer Center (IBCC), Quironsalud Group, 08017 Barcelona, Spain. Medica Scientia Innovation Research, 08007 Barcelona, Spain. Medica Scientia Innovation Research, Ridgewood, NJ 07450, USA. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid34299016
dc.identifier.wos000676513000001
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/CB16%2F12%2F00449
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple